University of Leeds
Research opens door to new thrombosis treatments
Published in Biotech Law Weekly, January 1st, 2010
Many of these patients currently take anticoagulant drugs such as Warfarin, which lower the risk of heart attacks or strokes by reducing the blood's ability to clot.
Although these drugs reduce the risk of dangerous blood clot formation within blood vessels (thrombosis), they also affect normal wound healing, leaving patients at risk of lethal bleeding if they injure themselves in any way.
Now, a team of scientists from the UK, Sweden, Germany, Holland and the USA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2010-01-01)
More Articles from Biotech Law Weekly
- Abramowitz & Pomerantz, P.A.
Federal Court Verdict Upholds $5.75 Million Legal Settlements in Drowning of Jazz Musician and Rabbi's Wife off Miami Beach - America's Charities
Don Sodo Retires After 22 Years as President and CEO of America's Charities - American Association of Neurological Surgeons AANS and Congress of Neurological Surgeons CNS
State and National Medical Societies Join Forces to Oppose Senator Reid's Health Reform Bill - American Optometric Association
AOA Backs Effort in Congress to Name New VA Blind Rehab Center in Honor of Fallen Soldier, Respected Doctor of Optometry - American Public Health Association
APHA Urges Senate to Advance Health Reform Bill - AVAX Technologies, Inc.
AVAX Technologies, Inc. Closes Bridge Financing - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
